Cargando…

Hydrophilic Matrix Tablets for Oral Controlled Release

This detailed volume addresses key issues and subtle nuances involved in developing hydrophilic matrix tablets as an approach to oral controlled release. It brings together information from more than five decades of research and development on hydrophilic matrix tablets and provides perspective on c...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Timmins, Peter (Editor ), Pygall, Samuel R. (Editor ), Melia, Colin D. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York, NY : Springer New York : Imprint: Springer, 2014.
Edición:1st ed. 2014.
Colección:AAPS Advances in the Pharmaceutical Sciences Series, 16
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-1-4939-1519-4
003 DE-He213
005 20220113013914.0
007 cr nn 008mamaa
008 141011s2014 xxu| s |||| 0|eng d
020 |a 9781493915194  |9 978-1-4939-1519-4 
024 7 |a 10.1007/978-1-4939-1519-4  |2 doi 
050 4 |a RS400-431 
072 7 |a PSB  |2 bicssc 
072 7 |a MED072000  |2 bisacsh 
072 7 |a PNB  |2 thema 
082 0 4 |a 615.19  |2 23 
245 1 0 |a Hydrophilic Matrix Tablets for Oral Controlled Release  |h [electronic resource] /  |c edited by Peter Timmins, Samuel R. Pygall, Colin D. Melia. 
250 |a 1st ed. 2014. 
264 1 |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 2014. 
300 |a IX, 326 p. 102 illus., 37 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a AAPS Advances in the Pharmaceutical Sciences Series,  |x 2210-738X ;  |v 16 
505 0 |a 1 Hydrophilic Matrix Dosage Forms: Definitions, General Attributes and the Evolution of Clinical Utilization -- 2 Design and Evaluation of Hydroxypropyl Methylcellulose Matrix Tablets for Oral Controlled Release: a Historical Perspective -- 3 An Industrial Perspective on Hydrophilic Matrix Tablets based on Hyproxypropyl Methylcellulose (Hypromellose) -- 4 Natural Polysaccharides in Hydrophilic Matrices -- 5 Applications of Polyethylene Oxide (POLYOX) in Hydrophilic Matrices -- 6 A Formulation Development Perspective on Critical Interactions Affecting the Performance of Hydrophilic Matrix Tablets -- 7 In vitro Physical and Imaging Techniques to Evaluate Drug Release Mechanisms from Hydrophilic Matrix Tablets -- 8 Physiologically-Based Pharmacokinetic Modelling in the Development and Evaluation of Hydrophilic Matrix Tablets -- 9 Approaches to Rapid In Vivo Optimization of Hydrophilic Matrix Tablets -- 10 Extrusion: an Enabling Technology for Controlled Release Hydrophilic Matrix Systems -- 11 Microenvironmental pH Control and Mixed Polymer Approaches to Optimize Drug Delivery with Hydrophilic Matrix Tablets -- 12 Evolving Biopharmaceutics Perspectives for Hydrophilic Matrix Tablets: Dosage Form-Food Interactions and Dosage Form Gastrointestinal Tract Interactions. 
520 |a This detailed volume addresses key issues and subtle nuances involved in developing hydrophilic matrix tablets as an approach to oral controlled release. It brings together information from more than five decades of research and development on hydrophilic matrix tablets and provides perspective on contemporary issues.  Twelve comprehensive chapters explore a variety of topics including polymers (hypromellose, natural polysaccharides and polyethylene oxide) and their utilization in hydrophilic matrices, critical interactions impacting tablet performance, in vitro physical and imaging techniques, and microenvironmental pH control and mixed polymer approaches, among others. In one collective volume, Hydrophilic Matrix Tablets for Oral Controlled Release provides a single source of current knowledge, including sections of previously unpublished data. It is an important resource for industrial and academic scientists investigating and developing these oral controlled release formulations. 
650 0 |a Pharmaceutical chemistry. 
650 1 4 |a Pharmaceutics. 
700 1 |a Timmins, Peter.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Pygall, Samuel R.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Melia, Colin D.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781493915200 
776 0 8 |i Printed edition:  |z 9781493915187 
776 0 8 |i Printed edition:  |z 9781493948277 
830 0 |a AAPS Advances in the Pharmaceutical Sciences Series,  |x 2210-738X ;  |v 16 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-1-4939-1519-4  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)